Arkolith/Insider Trading/CTXR/Form 4

Holuka Eugene Myron

DirectorCitius Pharmaceuticals, Inc. (CTXR) · full profile →Form 4 · filed Aug 30, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2024Option exercise(M)2K$0.02$482K
Mar 13, 2024Tax withholding(F)48$0.75$362K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2024Option exercise(M)2K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-074506) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML